Noxopharm engages Novotech for US regulatory strategy
Noxopharm (ASX:NOX) announced the engagement of Novotech to spearhead its US regulatory strategy.
Australiamtc
Resonance Health upgrades FY26 profit guidance
Perth-based medical technology firm Resonance Health (ASX:RHT) announced an upgrade to its financial guidance for the year ending June 30.
ImpediMed secures $15.2M for strategic growth
Medical technology innovator ImpediMed (ASX:IPD) announced a $15.2 million capital raise.
EBR Systems secures fast-track TGA approval path
EBR Systems (ASX:EBR) has secured priority review determination from the Therapeutic Goods Administration for its innovative WiSE cardiac resynchronisation therapy system.
BlinkLab raises $17.5M to accelerate FDA trials
Digital health pioneer BlinkLab (ASX:BB1) secured $17.5 million through an oversubscribed share placement.
Xenitra Q3 sales surge over 300%
Xenitra (ASX:XEN) reported a preliminary unaudited sales increase of over 300% for the third quarter.
Mesoblast acquires Mayo Clinic CAR-MSC technology licence
Mesoblast (ASX:MSB) has acquired an exclusive worldwide licence for a chimeric antigen receptor technology platform.
AVITA Medical data shows faster wound healing results
AVITA Medical (ASX:AVH) unveiled interim data from its Cohealyx-I multi-centre study.
Imricor Medical seeks FDA clearance for NorthStar System
Imricor Medical Systems (ASX:IMR) submitted its NorthStar 3D Mapping System for FDA clearance.
Enlitic secures US$1.2M contract with Parkland Health
Enlitic (ASX:ENL) announced a US$1.2 million imaging data migration contract with Parkland Health in Dallas, Texas.